Familial Amyotrophic Lateral Sclerosis (FALS) Study
Recruitment status was Recruiting
The goal of this study is to identify families with Amyotrophic Lateral Sclerosis (ALS). In addition, the investigators will identify families with ALS who may be eligible for the pre-fALS study or a clinical trial of arimoclomol in SOD1 positive familial ALS. For details of these studies, see independent entries on clincialtrials.gov.
Amyotrophic Lateral Sclerosis
|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
|Official Title:||Familial Amyotrophic Lateral Sclerosis (FALS) Study|
|Study Start Date:||February 2005|
Participation in this study involves a telephone conversation in which the investigators will draw your family tree, identifying those relatives who have had or currently have ALS. The investigators would also like study participants to donate a blood sample for research purposes.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00136500
|Contact: Eliana Reyesfirstname.lastname@example.org|
|United States, Florida|
|University of Miami||Recruiting|
|Miami, Florida, United States, 33136|
|Contact: Eliana Reyes 888-413-9315 email@example.com|
|Principal Investigator:||Michael Benatar, MD, PhD.||University of Miami|